Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.32
Delayed Data
As of 2:19pm ET
 -0.06 / -4.35%
Today’s Change
1.30
Today|||52-Week Range
5.70
-24.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
AssetsCash182.5M116.7M36.7M45.6M
 
 
 
 
 
Short Term Investment Cash18.1M-65.8M10.0M8.9M
 
 
 
 
 
Cash & Short Term Investments194.0M126.6M86.6M70.6M
 
 
 
 
 
 
ReceivablesReceivables1.1M6.3M7.6M19.1M
 
 
 
 
 
 
InventoriesInventories23.2M20.7M15.8M16.1M
 
 
 
 
 
 
Current AssetsOther Current Assets6.2M4.9M4.3M6.5M
 
 
 
 
 
Current Assets224.5M158.5M114.3M112.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.7M3.7M3.7M3.7M
 
 
 
 
 
Depreciation-2.6M-2.7M-2.9M-3.0M
 
 
 
 
 
Intangible Assets76.1M74.1M72.1M70.1M
 
 
 
 
 
Other Assets78.9M76.7M74.7M70.6M
 
 
 
 
 
Total Assets304.6M236.4M190.0M183.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable15.2M15.6M8.3M10.9M
 
 
 
 
 
Accrued Expenses12.9M9.9M11.4M9.9M
 
 
 
 
 
Other Current Liabilities42.8M30.1M28.4M38.4M
 
 
 
 
 
Other Liabilities65.4M49.5M41.8M56.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt166.2M177.2M171.5M171.6M
 
 
 
 
 
Total Liabilities244.2M240.9M228.7M242.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock3.3M3.3M3.3M3.3M
 
 
 
 
 
Common Equity57.0M-7.9M-42.0M-62.4M
 
 
 
 
 
Total Shareholder Equity60.4M-4.5M-38.7M-59.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.6M15.2M15.3M15.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.